These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 16896285)
21. Challenges and opportunities in SLE clinical trials. van Vollenhoven RF Curr Opin Rheumatol; 2013 Sep; 25(5):606-15. PubMed ID: 23917158 [TBL] [Abstract][Full Text] [Related]
22. The efficacy of antimalarials in systemic lupus erythematosus. Nayak V; Esdaile JM Lupus; 1996 Jun; 5 Suppl 1():S23-7. PubMed ID: 8803906 [TBL] [Abstract][Full Text] [Related]
23. SiLEncing SLE: the power and promise of small noncoding RNAs. Rigby RJ; Vinuesa CG Curr Opin Rheumatol; 2008 Sep; 20(5):526-31. PubMed ID: 18698172 [TBL] [Abstract][Full Text] [Related]
24. Lessons learned from clinical trials in SLE. Strand V Autoimmun Rev; 2007 Mar; 6(4):209-14. PubMed ID: 17317609 [TBL] [Abstract][Full Text] [Related]
25. Clinical trials for lupus--are we there yet? Merrill JT Bull NYU Hosp Jt Dis; 2009; 67(3):267-70. PubMed ID: 19852748 [No Abstract] [Full Text] [Related]
26. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
27. Update on emerging drug therapies for systemic lupus erythematosus. Mok CC Expert Opin Emerg Drugs; 2010 Mar; 15(1):53-70. PubMed ID: 20148712 [TBL] [Abstract][Full Text] [Related]
29. Better conduct of clinical trials: the control group in critical care trials. Takala J Crit Care Med; 2009 Jan; 37(1 Suppl):S80-90. PubMed ID: 19104230 [TBL] [Abstract][Full Text] [Related]
36. Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus. Goldblatt F; Isenberg DA Handb Exp Pharmacol; 2008; (181):163-81. PubMed ID: 18071946 [TBL] [Abstract][Full Text] [Related]
37. Barriers to a trial of atherosclerosis prevention in systemic lupus erythematosus. Costenbader KH; Karlson EW; Gall V; de Pablo P; Finckh A; Lynch M; Bermas B; Schur PH; Liang MH Arthritis Rheum; 2005 Oct; 53(5):718-23. PubMed ID: 16208639 [TBL] [Abstract][Full Text] [Related]
38. Phase II clinical trial design: methods in translational research from the Genitourinary Committee at the Eastern Cooperative Oncology Group. Gray R; Manola J; Saxman S; Wright J; Dutcher J; Atkins M; Carducci M; See W; Sweeney C; Liu G; Stein M; Dreicer R; Wilding G; DiPaola RS Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1966-9. PubMed ID: 16609005 [TBL] [Abstract][Full Text] [Related]
39. Biomarkers, surrogate markers, and design of clinical trials of new therapies for systemic lupus erythematosus. Schiffenbauer J; Hahn B; Weisman MH; Simon LS Arthritis Rheum; 2004 Aug; 50(8):2415-22. PubMed ID: 15334452 [No Abstract] [Full Text] [Related]
40. Design and endpoints of clinical trials in hepatocellular carcinoma. Llovet JM; Di Bisceglie AM; Bruix J; Kramer BS; Lencioni R; Zhu AX; Sherman M; Schwartz M; Lotze M; Talwalkar J; Gores GJ; J Natl Cancer Inst; 2008 May; 100(10):698-711. PubMed ID: 18477802 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]